Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
Authors:
- Charles GillhamCGCharles Gillham
- Mary DunneMDMary Dunne
- Ian FraserIFIan Fraser
- Donal HollywoodDHDonal Hollywood
- John ArmstrongJAJohn Armstrong
- Pierre ThirionPTPierre Thirion
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 98 (1) , 38-41
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cetuximab is Effective, but more Toxic than Reported in the Bonner TrialClinical Oncology, 2008
- Severe skin reaction secondary to concomitant radiotherapy plus cetuximabRadiation Oncology, 2008
- Acneiform rash secondary to cetuximab plus head and neck radiotherapyRadiotherapy and Oncology, 2007
- Severe Cutaneous Reaction during Radiation Therapy with Concurrent CetuximabNew England Journal of Medicine, 2007
- Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With CetuximabJournal of Clinical Oncology, 2007
- Mechanisms of cutaneous toxicities to EGFR inhibitorsNature Reviews Cancer, 2006
- Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC TrialJournal of Clinical Oncology, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006
- Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptorCarcinogenesis, 2005
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999